Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9748 |
High Similarity |
NPD7472 |
Approved |
0.9686 |
High Similarity |
NPD7054 |
Approved |
0.9568 |
High Similarity |
NPD7808 |
Phase 3 |
0.9506 |
High Similarity |
NPD7251 |
Discontinued |
0.9503 |
High Similarity |
NPD7074 |
Phase 3 |
0.9444 |
High Similarity |
NPD6797 |
Phase 2 |
0.9024 |
High Similarity |
NPD3818 |
Discontinued |
0.9 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8982 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.897 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8902 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8902 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8902 |
High Similarity |
NPD6166 |
Phase 2 |
0.8758 |
High Similarity |
NPD3817 |
Phase 2 |
0.875 |
High Similarity |
NPD1934 |
Approved |
0.858 |
High Similarity |
NPD2801 |
Approved |
0.858 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8364 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8314 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8253 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8242 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8084 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8035 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7989 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7988 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7966 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7953 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7874 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7829 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD37 |
Approved |
0.775 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7719 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7719 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7654 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.765 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD919 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7604 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7449 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7449 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7448 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7385 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD447 |
Suspended |
0.732 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7312 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7306 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD943 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7251 |
Intermediate Similarity |
NPD920 |
Approved |
0.725 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7245 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.724 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7235 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7235 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7135 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7118 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7043 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6385 |
Approved |
0.6989 |
Remote Similarity |
NPD6386 |
Approved |
0.6979 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6979 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD5242 |
Approved |
0.6954 |
Remote Similarity |
NPD5006 |
Approved |
0.6954 |
Remote Similarity |
NPD5005 |
Approved |
0.6951 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6928 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6909 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD9494 |
Approved |
0.6871 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6862 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6852 |
Remote Similarity |
NPD1203 |
Approved |
0.6848 |
Remote Similarity |
NPD3268 |
Approved |
0.6848 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2654 |
Approved |
0.6837 |
Remote Similarity |
NPD4420 |
Approved |
0.6832
|
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |